The Duke Comprehensive Cancer Center in Durham, N.C., has received a five-year, $30 million core grant renewal from NCI to support its clinical, research, and educational programs. The award means the center retains its designation as one of 40 U.S. cancer institutions deemed “comprehensive” by the NCI.
“This renewal comes at an exciting and transformative time in the history of cancer research, treatment, and teaching within Duke medicine and supports Duke’s national reputation for excellence in cancer care,” said Victor J. Dzau, MD, chancellor of health affairs and CEO, Duke Health System.
The grant comes at a time when Duke is expanding its cancer program through additional local, regional and statewide affiliations and building a new, state-of-theart, multidisciplinary cancer care center scheduled to open in early 2012.
The Duke Comprehensive Cancer Center was established in 1972 and has benefited from continuous recognition and funding from the NCI since 1973, when it was named as one of the original eight comprehensive cancer centers.
In other news, H. Kim Lyerly, MD, director of the Duke Comprehensive Cancer Center, has been appointed to serve on two councils at NIH: the Council of Councils, which advises the NIH director on the policies and activities of the division of program coordination, planning, New Jersey cancer center features green lobby The John Theurer Cancer Center at Hackensack University Medical Center in New Jersey opened its new $130-million comprehensive care facility. The cancer center building will house 14 specialized divisions, including research and auxiliary oncology services, nutrition counseling, psychosocial support, and complementary therapies. The centerpiece of the lobby is a “living wall” with a 24-foot waterfall and more than 30 hydroponically grown plant species (above). The project was funded with $65 million raised by the Hackensack University Medical Center and with a $10 million donation from Helena Theurer, in memory of her husband John Theurer. n and strategic initiatives, and the Office of AIDS Research Advisory Council, which guides several federal entities on AIDS policy.
A 48-year-old female presents with complaints of irregular vaginal bleeding and postcoital bleeding. Images from a PET/CT and pelvis MRI reveal characteristic findings. What is your diagnosis?
